These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22209925)

  • 1. Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
    Mocchegiani E; Giacconi R; Costarelli L
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S11-9. PubMed ID: 22209925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
    Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
    Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
    Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, chronic obstructive pulmonary disease and aging.
    Provinciali M; Cardelli M; Marchegiani F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S3-10. PubMed ID: 22209928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
    van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
    Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.
    McAloon CJ; Wood AM; Gough SC; Stockley RA
    Ther Adv Respir Dis; 2009 Feb; 3(1):23-30. PubMed ID: 19293200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
    Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
    J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
    van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
    Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.
    Hernández-Montoya J; Pérez-Ramos J; Montaño M; Ramírez-Venegas A; Sansores RH; Pérez-Rubio G; Velázquez-Uncal M; Camarena A; Ramos C; Falfán-Valencia R
    Biomark Med; 2015; 9(10):979-88. PubMed ID: 26439471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
    Brzóska K; Bartłomiejczyk T; Sochanowicz B; Cymerman M; Grudny J; Kołakowski J; Kapka-Skrzypczak L; Kruszewski M; Sliwiński P; Roszkowski-Śliż K
    Ann Agric Environ Med; 2014; 21(3):546-51. PubMed ID: 25292126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
    Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
    Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD).
    Daheshia M
    Curr Med Res Opin; 2005 Apr; 21(4):587-94. PubMed ID: 15899108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.